- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Melanoma, Stage II in South Africa
Total 941 results
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedMetastatic MelanomaUnited States, Canada, Belgium, Spain, France, Russian Federation, Australia
-
The Medicines CompanyCompletedHomozygous Familial HypercholesterolemiaUnited States, Netherlands, South Africa
-
TakedaCompletedMelanoma | NeoplasmsUnited States, Australia
-
Hoffmann-La RocheCompleted
-
Novartis PharmaceuticalsTerminatedUveal MelanomaUnited States, Australia, France, Netherlands, Spain, Norway
-
Melanoma Institute AustraliaActive, not recruiting
-
Aura BiosciencesRecruitingChoroidal Melanoma | Indeterminate Lesions of EyeUnited States
-
University of PennsylvaniaUniversity of Amsterdam; University of Cape Town; University of Witwatersrand...RecruitingHomozygous Familial HypercholesterolemiaUnited States, Netherlands, South Africa
-
Mayo ClinicCompletedMultiple Myeloma | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
PfizerCompletedLocally Advanced or Metastatic NRAS Mutant MelanomaUnited States, Australia, Germany, Italy, Netherlands
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI); NCIC Clinical Trials Group; Children's Oncology... and other collaboratorsActive, not recruitingMelanoma (Skin)United States, Canada, Australia, South Africa
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute Australia; Cancer Council New South WalesActive, not recruitingMetastatic Melanoma to the Groin Lymph NodesUnited Kingdom, Slovenia, Australia, Brazil, Netherlands, Italy
-
ActelionCompleted
-
Bristol-Myers SquibbMedarexCompletedMelanomaFrance, United States, Australia, Belgium, Germany, South Africa, Canada, Brazil, Czech Republic, Hungary
-
Idera Pharmaceuticals, Inc.Bristol-Myers SquibbTerminatedMetastatic MelanomaUnited States, Canada, Spain, United Kingdom, France, Australia, Germany, Italy, Netherlands, Sweden, Czechia
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
Eisai Inc.CompletedMetastatic MelanomaUnited States, Australia, United Kingdom, Germany
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
CelgeneICON Clinical ResearchCompletedMelanoma | Neoplasm MetastasisAustralia, United Kingdom, Ukraine, Germany, Estonia, Latvia, Lithuania, Netherlands, South Africa
-
Hoffmann-La RocheTerminatedMalignant MelanomaUnited States, France, Australia, United Kingdom, Italy, Spain, Germany, Israel, Poland, Slovakia
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownLymphedema | Stage II Uterine Corpus Cancer | Stage IVB Vulvar Cancer | Stage IA Uterine Corpus Cancer | Stage IB Uterine Corpus Cancer | Stage IA Cervical Cancer | Stage IB Cervical Cancer | Stage II Vulvar Cancer | Stage IIA Cervical Cancer | Stage IA Vulvar Cancer | Stage IB Vulvar Cancer | Stage IIIA Vulvar... and other conditionsUnited States
-
Merck Sharp & Dohme LLCEisai Inc.CompletedAdvanced MelanomaCanada, United States, Australia, Spain, Sweden
-
IDEAYA BiosciencesRecruitingUveal MelanomaUnited States, Australia, Canada, Netherlands, Italy, France, Germany, United Kingdom
-
Piramal Enterprises LimitedCompletedMelanomaAustralia, India, New Zealand
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage II Breast Cancer AJCC v8 | Prognostic Stage IIA Breast Cancer AJCC v8 | Prognostic Stage IIB Breast Cancer... and other conditionsUnited States, Puerto Rico
-
PfizerCompletedMelanoma and Metastatic Colorectal CancerUnited States, Spain, France, Japan, Australia, Switzerland, Norway
-
Bristol-Myers SquibbCompletedMelanomaSouth Africa, United States, Spain, France, Italy, Belgium, Austria, Israel, Germany, Norway, Canada, Brazil, Poland, Denmark, Czech Republic, Russian Federation, Ukraine, Argentina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaSpain, United States, Australia, France, Israel, Italy, South Africa, Switzerland
-
Novartis PharmaceuticalsRecruitingMetastatic Uveal MelanomaUnited States, Australia, France, Netherlands, Switzerland, Germany, Spain
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Bristol-Myers SquibbCompletedMelanomaAustralia, France, Italy, Poland, United Kingdom, United States, Spain, Belgium, Denmark, Germany, Norway, Switzerland, Argentina, Austria, Sweden, Czechia, Hungary, Netherlands, Mexico, Canada, Israel, South Africa
-
GlaxoSmithKlineCompletedMelanomaAustralia, United States
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
Mural Oncology, IncRecruitingCutaneous Melanoma | Mucosal MelanomaUnited States, Australia, Canada, Italy, Korea, Republic of, Spain, Taiwan, United Kingdom
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedRecurrent MelanomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B; SWOG Cancer Research...CompletedMelanoma (Skin)United States
-
Genentech, Inc.BioNTech SEActive, not recruitingAdvanced MelanomaUnited States, Spain, Belgium, Australia, Germany, United Kingdom
-
Bristol-Myers SquibbCompletedAdvanced Cutaneous MelanomaGermany, Poland, Spain, Australia, France, Argentina, Ireland, Israel, Belgium, United States, Switzerland, United Kingdom, Greece, Austria, Canada
-
AstraZenecaCompletedRefractory MelanomaUnited States, Spain, Canada, France, Italy, United Kingdom, Argentina, Australia, Germany
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMetastatic Cancer | Melanoma (Skin)United States
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Sarcoma | Recurrent Uterine Corpus Carcinoma | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer | Recurrent Cervical Carcinoma | Stage III Uterine Sarcoma | Stage IV Uterine Sarcoma | Stage I Uterine... and other conditionsUnited States
-
NRG OncologyNational Cancer Institute (NCI)SuspendedStage II Breast Cancer | Stage IIIA Breast Cancer | Invasive Breast Carcinoma | Stage IIA Breast Cancer | Stage IIB Breast CancerUnited States, Canada
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMalignant MelanomaUnited States, Australia, Austria, Brazil, Canada, Chile, China, France, Germany, Israel, Italy, Korea, Republic of, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom